Perempuan, Pil KB, dan Batu Empedu: Hubungan Durasi Kontrasepsi dengan Risiko Cholelithiasis

Authors

  • Feliciana Kwando Universitas Ciputra Surabaya
  • Yuswanto Setyawan Universitas Ciputra Surabaya

DOI:

https://doi.org/10.28926/briliant.v10i4.2339

Keywords:

Oral contraceptives, cholelithiasis, duration of use, reproductive health, hormonal risk

Abstract

The use of oral contraceptive pills (OCPs) is widely recognized as an effective method of birth control among women of reproductive age. However, prolonged exposure to synthetic estrogen and progesterone may pose a risk for gallstone formation (cholelithiasis). This study aimed to investigate the association between the duration of OCP use and the incidence of cholelithiasis in reproductive-age women. Employing a quantitative cross-sectional approach, 100 purposively selected female respondents aged 20–45 years were assessed through structured questionnaires, interviews, and confirmed ultrasonography (USG) results. Statistical analyses using Chi-Square and Spearman’s rank correlation revealed a significant relationship between longer duration of pill use and increased risk of gallstone formation (p < 0.05). These findings underscore the hepatobiliary impact of long-term hormonal contraceptive use, even in asymptomatic users. The novelty of this research lies in highlighting duration as a predictive factor, which has not been emphasized in current family planning policies. This study recommends integrating risk-based contraceptive counseling and early detection protocols into primary health care services, particularly for long-term users. Further longitudinal studies are necessary to confirm causal relationships and expand the applicability of these findings.

References

Aune, D., Norat, T., & Vigna, L. (2020). Body mass index, physical activity and the risk of gallstone disease: A systematic review and dose response meta analysis of prospective studies. European Journal of Epidemiology, 35(8), 745–760. https://doi.org/10.1007/s10654-020-00682-2

Chen, X., Zhang, Y., & Wang, L. (2021). Effects of estrogen and progesterone on gallbladder motility: A systematic review. Frontiers in Endocrinology, 12, 633614. https://doi.org/10.3389/fendo.2021.633614

Dawson, J. A., & Chow, K. (2020). Hormonal contraceptive use and gallbladder disease: An analysis of hormonal impact. Journal of Women’s Health, 29(11), 1421–1429. https://doi.org/10.1089/jwh.2020.8331

Friedman, G. D., et al. (2020). The risk of gallbladder disease in relation to hormone use in women. Annals of Internal Medicine, 172(2), 77–83. https://doi.org/10.7326/M19-2314

Gurusamy, K. S., et al. (2018). Surgical versus medical treatment for gallstones. Cochrane Database of Systematic Reviews, 6, CD007088. https://doi.org/10.1002/14651858.CD007088.pub3

Huang, X., Li, Z., & Wang, C. (2019). Oral contraceptives and risk of gallstones: A meta-analysis. American Journal of Obstetrics & Gynecology, 220(2), 122–130. https://doi.org/10.1016/j.ajog.2019.08.050

Lammert, F., et al. (2016). Gallstones. Nature Reviews Disease Primers, 2, 16024. https://doi.org/10.1038/nrdp.2016.24

Lim, S. Y., & Koh, S. J. (2020). Estrogen related gallstone formation: Clinical perspectives. Clinical Gastroenterology and Hepatology, 18(3), 553–561. https://doi.org/10.1016/j.cgh.2019.08.010

McKay, G., et al. (2021). Impact of hormonal contraceptive use on liver function and gallbladder disease. Journal of Clinical Gastroenterology, 55(5), 421–428. https://doi.org/10.1097/MCG.0000000000001444

Mendez Sanchez, N., et al. (2019). Risk factors associated with gallstone disease in female populations. Annals of Hepatology, 18(1), 112–118. https://doi.org/10.1016/j.aohep.2018.10.004

Nasser, A., et al. (2020). Incidence of gallstone formation in women using oral contraceptives: A retrospective cohort study. World Journal of Gastroenterology, 26(30), 4502–4510. https://doi.org/10.3748/wjg.v26.i30.4502

Nickerson, H., & Barnett, T. (2021). Gallstones in women: A rising concern for long term OC users. Women’s Health Reports, 2(3), 151–158. https://doi.org/10.1089/whr.2021.0015

Portincasa, P., et al. (2016). Pathophysiology and natural history of gallstones. Best Practice & Research Clinical Gastroenterology, 30(5), 593–607. https://doi.org/10.1016/j.bpg.2016.09.005

Reed, C. M., & Morrison, J. (2021). Revisiting contraceptive safety: Cholelithiasis as a metabolic consideration. Reproductive Health, 18(1), 101–110. https://doi.org/10.1186/s12978-021-01030-5

Schafer, M., et al. (2020). Oral contraceptives and hepatobiliary system: What clinicians should know. BMJ Open Gastroenterology, 7(1), e000501. https://doi.org/10.1136/bmjgast-2019-000501

Sedgh, G., et al. (2016). Contraceptive use and need worldwide in 2016: An overview of global trends. Guttmacher Institute Report, 1–32. (No DOI)

Shabanzadeh, D. M. (2020). Incidence of gallstone disease: Influence of body composition and hormones. Scandinavian Journal of Gastroenterology, 55(3), 319–325. https://doi.org/10.1080/00365521.2020.1734261

Shepherd, J., et al. (2020). Estrogens and gallbladder disease: A review of mechanisms. Hormone Molecular Biology and Clinical Investigation, 41(1), 87–93.

Stinton, L. M., & Shaffer, E. A. (2018). Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut and Liver, 6(2), 172–187. https://doi.org/10.5009/gnl18255

Tan, A., & Teoh, B. (2019). Influence of hormonal changes on gallstone formation. Journal of Gastroenterology and Hepatology Research, 8(6), 3051–3056.

Thakur, R., et al. (2021). Risk of cholelithiasis in relation to hormonal contraception. British Journal of Clinical Pharmacology, 87(12), 4621–4629. https://doi.org/10.1111/bcp.14706

Tsai, C. J., et al. (2018). Estrogen and progesterone therapy and gallstone risk: A national study. Journal of Women’s Health, 27(7), 892–898.

Valentine, K., & Baxter, K. (2020). Cholelithiasis and reproductive health: An integrative review. Nursing Women’s Health, 24(5), 324–331.

Venneman, N. G., et al. (2017). The impact of contraceptive use on gallstone formation in premenopausal women. Hepatology Research, 47(1), 34–41.

Wu, X., et al. (2020). Long term oral contraceptive use and metabolic disturbances. Endocrine Reviews, 41(3), 401–423. https://doi.org/10.1210/endrev/bnz007

Zhang, Y., et al. (2019). Oral contraceptive use and risk of cholelithiasis: A systematic review and meta analysis. Contraception, 99(2), 71–77. https://doi.org/10.1016/j.contraception.2018.10.007

Published

19-11-2025

Issue

Section

Mathematics and Natural Science